Navigation Links
Toward understanding the dangers of the fake marijuana called 'Spice' or 'K2'
Date:10/2/2013

The harmful effects of increasingly popular designer cannabis products called "Spice" or "K2" have puzzled scientists for years, but now a group of researchers is reporting progress toward understanding what makes them so toxic. The study, published in the ACS journal Analytical Chemistry, describes development of a method that could someday help physicians diagnose and treat the thousands of young adults and teens who end up in emergency rooms after taking the drugs.

Jeffery Moran and colleagues note that synthetic marijuana, often marketed as "natural incense," "potpourri," Spice or K2, is a significant public health concern, and 1 in 9 high school seniors admit recent use. The products appear across the United States and Europe, and are the second most popular drug after real marijuana for many American teens and young adults. The substances produce a "high," but also can cause a wide range of dangerous side effects including seizures, hallucinations, severe kidney damage, psychotic behavior and heart attacks. Scientists are quickly playing catch-up to understand how these fake pot products work in order to identify them in users' urine and to treat the devastating health effects, which, in some cases, plague users for months after they initially take it.

To gain insight into the effects of designer marijuana products, Moran's team developed a new method and used it to study how the body processes two popular forms in Spice and K2, known as JWH-018 and AM2201. Urine samples from 15 people who tested positive for use showed significant differences in how the individuals' bodies processed the drugs. This finding could help explain why some people experience more severe effects from the drugs than others.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Insect-inspired super rubber moves toward practical uses in medicine
2. Toward a safer form of acetaminophen
3. New materials, progress toward an HIV vaccine, and more at meeting of crystallographers
4. UCLA stem cell gene therapy for sickle cell disease advances toward clinical trials
5. Toward broad-spectrum antiviral drugs for common cold and other infections
6. NREL drives toward the future with fuel cell EVs
7. Engineered stem cell advance points toward treatment for ALS
8. A giant step toward miniaturization
9. The large-scale EU project EU BON: Towards integration with its global counterpart GEO BON
10. Towards more sustainable construction
11. Report: Water and Agriculture in Canada: Towards Sustainable Management of Water Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)... TEANECK, N.J. , May 16, 2017  Veratad ... leading provider of online age and identity verification solutions, ... the K(NO)W Identity Conference 2017, May 15 thru May ... Ronald Regan Building and International Trade Center. ... across the globe and in today,s quickly evolving digital ...
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
(Date:4/11/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 30.37% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Biology News(10 mins):
(Date:7/20/2017)... CA (PRWEB) , ... July 20, 2017 , ... Corporate ... governance at its 27th annual Director of the Year Awards. , The awards will ... La Jolla. This annual event celebrates directors who have made significantly positive contributions ...
(Date:7/18/2017)... Basel, Switzerland (PRWEB) , ... July 18, 2017 ... ... for R&D, today announced that Merck, a leading science and technology company, has ... develop innovative therapeutics for the therapeutic areas of Oncology, Immunology, and Neurodegenerative Diseases. ...
(Date:7/18/2017)... ... 2017 , ... Recently recognized by CIO Magazine as a ... of its flagship cloud-based product Planet Life Cycle – a robust work management ... that merges strategic and financial planning with execution. The solution is leveraged to ...
(Date:7/17/2017)... ... July 17, 2017 , ... OHAUS Corporation, ... the launch of its new line of Heavy-Duty Orbital Shakers today. , Eight ... and digital) for laboratory applications. These shakers are ideal for load capacities ...
Breaking Biology Technology: